2011 - maintenantpharmaLevers GmbH is a market access and reimbursement consulting firm for the pharmaceutical, medical device and health care industries. Focus on value transformation to the payer and decision makers’ perspective.
- Optimizing market access process
- Bridging and aligning stakeholder’s value perception
- Translating pharmacoeconomic results into the payer and decision
makers perspective
- Enabling sales team to value based selling
pharmaLevers GmbH is offering the following Services:
o Market Access
o Payer Marketing
o HEOR Value Translation
o Pricing & Reimbursement
o Policy Analysis
o HTA Lever
Haifa2010 - 2011this European HQ Position with focus on market access in Central Europe is embedded in a global matrix organization. Key task is to accelerate and optimize market access, reimbursement and market penetration by creating stakeholder specific value messages based on clinical and health economic evidence.
- Evaluation and interpretation of DRG’s and Coding
- Due diligence for innovative MedTec opportunities
- Creating value messages and dossiers
- Special focus on HTA
- Eucation of German and Swiss field force in health care issues,DRG’s
and Health Economics
Mepha Pharma AG
- Manager Pharmaceutical Policy
2006 - 2009- Advice and policy making for pharmaceutical economics and policies
for the Swiss Generic Association INTERGENERIKA
- Management of national and international price comparison studies
e.g. price comparison of Switzerland, Germany, France, Italy and Austria
- Comparison of the UK, French, German and Swiss Health Care and Generic Market
- Critical appraisals of international price comparison studies e.g. IMS,
EFPIA, OFT (UK), Eurostat
- Evaluation of pharmaceutical policies across Europe especially in the
area of pricing & reimbursement and rebate & discount
Deloitte Consulting
- Senior Consultant
Puteaux1999 - 1999-Evaluation of the Swiss Health Care market as an European pilot to investigate whether it would be worthwhile to enter the European health care consulting business
- Evaluation of Deloitte’s methodologies for European suitability
- Project on sales force effectiveness
- Benchmark study how “Big Pharma” is managing small markets in Africa,
Middle East and CEE
Arcovita AG ( Payer)
- Head Pharmaceutical Department
1997 - 1998the Swiss Managed Care Organization of two major sickness funds covering one third of the Swiss population with an annual drug budget of 500 Mio USD
- Design and implementation of new, innovative health care solutions to
improve quality, outcome and costs
- US Managed Care study visits of J&J, SKB, Lilly, BMS, S-P, Merck
- Working in a high level interdisciplinary team with physicians
(surgery, prevention, GP’s), insurance-, economy-, sociology- and
marketing- experts
- Management of a mail order pharmacy
- Pricing studies on PPI’s with basic HTA approach
F. Hoffmann La Roche
- Product- and Medical Manager
1991 - 1996- Responsible for Biotech products in the area of oncology, viral hepatitis
and HIV
- Marketing launch of Interferon-alpha (on a indication basis),
Interleukin-2, Ganciclovir, Saquinavir, Zalcitabine and Tretinoin
- Implementing global ex-factory price for a HIV drug(first proteinase inhibitor)
- In-licensing Interleukin-2 from EuroCetus and generating sales without
federal approval and reimbursement
- Design and implementation of 14 clinical trials
